Cynthia E. Balatoni, Ph.D.

2008 University of California, Los Angeles, Los Angeles, CA 
"Cynthia Balatoni"


Sign in to add mentor
Michael Teitell grad student 2008 UCLA
 (Investigations in TCL1-mediated lymphomagenesis involving polynucleotide phosphorylase and STK39 hypermethylation.)
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Balatoni CE, Dawson DW, Suh J, et al. (2009) Epigenetic silencing of Stk39 in B-cell lymphoma inhibits apoptosis from genotoxic stress. The American Journal of Pathology. 175: 1653-61
Frank MJ, Dawson DW, Bensinger SJ, et al. (2009) Expression of sprouty2 inhibits B-cell proliferation and is epigenetically silenced in mouse and human B-cell lymphomas. Blood. 113: 2478-87
Vaysberg M, Balatoni CE, Nepomuceno RR, et al. (2007) Rapamycin inhibits proliferation of Epstein-Barr virus-positive B-cell lymphomas through modulation of cell-cycle protein expression. Transplantation. 83: 1114-21
French SW, Dawson DW, Chen HW, et al. (2007) The TCL1 oncoprotein binds the RNase PH domains of the PNPase exoribonuclease without affecting its RNA degrading activity. Cancer Letters. 248: 198-210
Chen HW, Rainey RN, Balatoni CE, et al. (2006) Mammalian polynucleotide phosphorylase is an intermembrane space RNase that maintains mitochondrial homeostasis Molecular and Cellular Biology. 26: 8475-8487
Nepomuceno RR, Balatoni CE, Natkunam Y, et al. (2003) Rapamycin inhibits the interleukin 10 signal transduction pathway and the growth of Epstein Barr virus B-cell lymphomas. Cancer Research. 63: 4472-80
See more...